ESS vs XENE · P/E 31, rev $489.0M vs $2.55B cap
Essex Property Trust Inc (ESS) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported ESS revenue for 2026-06-30 was $489.0M. Net income was $66.9M. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. XENE currently screens at market cap $2.55B.
Not investment advice. Open the ESS and XENE stock pages for the full models.
Not investment advice.